Key facts
- This page summarizes Stephen Gordon's Form 4 filing for TransMedics Group, Inc. (TMDX).
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 02 May 2023, 18:31.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Options Exercise
Sale
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
Options Exercise
Additional SEC filing notes
Footnote F1
The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on December 16, 2022.
Footnote F2
Includes 13,075 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock.
Footnote F3
The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on February 27, 2024.